Short answer: no CBD cream has been shown to be the best for pain, and the research doesn’t rank creams against each other. The two controlled trials of CBD applied to the skin are small, one was positive and one was not, and the FDA has not approved any CBD cream. Here is what to check before you pay, and what those trials actually measured.

Is CBD cream legit, and has the FDA approved it?
You can buy CBD cream in the US, but none of them is FDA-approved. The FDA’s consumer update on CBD says the agency has approved only one CBD product, a prescription drug for seizures associated with Lennox Gastaut syndrome, Dravet syndrome or tuberous sclerosis complex in people one year of age and older. Beyond that, the FDA has not approved any other CBD products, creams and gummies included.
The same update says it is currently illegal to market CBD by adding it to a food or labeling it as a dietary supplement. It also warns that some CBD products are marketed with unproven medical claims and are of unknown quality.
In practice, a legitimate seller is one you can identify, with a product that carries no FDA review for what its label claims. The FDA says unapproved CBD products have not been evaluated for whether they are effective for a particular disease or for other claimed effects.
Does CBD cream work for pain, according to the research?
The research on CBD applied to the skin is thin. Both trials below focused on nerve pain, not joint or muscle pain, and both compared CBD only with placebo.
The 2020 topical trial in peripheral neuropathy
A four-week randomized, placebo-controlled trial published in Curr Pharm Biotechnol in 2020 enrolled 29 people with symptomatic peripheral neuropathy of the lower extremities. Fifteen were randomized to CBD and 14 to placebo. The CBD product contained 250 mg of CBD per 3 fl. oz. The 2020 neuropathy trial abstract reports a statistically significant reduction in intense pain, sharp pain, and cold and itchy sensations in the CBD group compared with placebo, and says no adverse events were reported. The average age was 68, and 62.1% of participants were male.
The study describes its product as a topical CBD oil, not a cream. The authors wrote that “the transdermal application of CBD oil can achieve significant improvement in pain and other disturbing sensations in patients with peripheral neuropathy.” With 29 people over four weeks, this is a signal to read, not a result you can expect from the cream on a shelf.
The 2024 topical cream trial in chemotherapy-related neuropathy
This pilot trial, published in Cannabis Cannabinoid Res. in 2024 (ClinicalTrials.gov NCT05388058), randomized 40 people with established chemotherapy-induced peripheral neuropathy to a CBD cream or a placebo cream. Each was applied for two weeks, followed by a two-week crossover. EORTC-CIPN20 scores were similar in the CBD and placebo groups, and so were toxicity scores. The authors concluded that the trial “did not support that the studied CBD isolate cream improved painful established CIPN,” and said the cream was well tolerated overall.
The negative result counts as much as the positive one. In this trial, the cream did not beat placebo.
The oral fibromyalgia trial
This trial used CBD by mouth, not on the skin. A Danish randomized, double-blind trial (fibromyalgia CBD trial abstract) assigned 200 people with fibromyalgia to 50 mg of plant-derived CBD daily or placebo tablets for 24 weeks. On a 0 to 10 pain scale, pain fell by 0.4 points in the CBD group and 1.1 points in the placebo group, a between-group difference of 0.7 points favouring placebo. The authors wrote that the findings “do not support CBD 50 mg daily as an analgesic supplement for patients with fibromyalgia.”
The wider pain research
The NCCIH’s cannabis overview says some evidence suggests modest benefits of cannabis or cannabinoids for chronic pain. It summarizes a 2018 review of 47 studies (4,743 participants) of cannabis or cannabinoids for chronic pain other than cancer pain. Twenty-nine percent of people taking them had a 30% reduction in pain, against 26% on placebo. NCCIH notes the difference may be too small to be meaningful to patients, and that side effects were more common among people taking cannabinoids. For more on the pain picture, see cbd for pain relief.
Is CBD cream better than Voltaren?
Neither topical trial compared CBD with another pain product, so there is no research answer on how a CBD cream stacks up against Voltaren. Both compared CBD with placebo. A pharmacist can help you weigh which option fits the pain you have and the medicines you already take.
What is the best CBD cream for pain? What to check before you pay
This guide doesn’t name a best cream or rank creams by strength, because the research doesn’t measure one brand against another. What you can do is check the same few things on every label. The same check applies if you’re comparing CBD oils.
| What to check | What it tells you | Why it matters for a cream |
|---|---|---|
| CBD milligrams per container | Total CBD in the whole bottle, jar or tube | The number to compare across products. Use the label’s figure, not words like “strong.” |
| Spectrum: full, broad or isolate | Which other plant compounds, if any, are in the extract | Changes what else is in the product, including THC in full-spectrum versions. |
| THC amount | The THC line on the lab report | Shows whether THC is present and how much. |
| Other active ingredients | Menthol, camphor, essential oils and similar | Cooling and warming ingredients are often what you feel first. They are not CBD. |
| Lab report for the lot | CBD and contaminant results for the batch you would receive | The FDA says some CBD products are of unknown quality, so the report should match the batch. |
| Seller identity | Who makes and sells the product | FDA has issued warning letters to firms marketing CBD products for disease or other therapeutic uses. |
| Product claims | What the label says the product is for | FDA has not approved a CBD cream for pain. |
| Return terms | What you can do if the product isn’t right | Read them before you pay. |
On the question of the most trusted brand, the test is the same for every seller: a lab report for the batch you’d receive, a seller you can identify, and return terms you can read before you pay. The FTC’s health-products compliance guidance says a health claim needs research that meets accepted norms in the field it concerns. A pain claim on a label should be able to point to that kind of research.
Watch the word hemp. Hemp on a label does not show a CBD amount. A product confirmed to contain CBD is called CBD gummies, while hemp gummies is a broad shopping term that can cover hemp-seed products, CBD-containing hemp products and THC-containing products. The same logic applies here: if the label gives no milligram figure, you can’t compare it. For gummies specifically, see cbd gummies for arthritis pain.
Cream, balm or roll-on: does the format change anything?
The format changes how you apply the product, not what the CBD is. Nothing But Canna’s label guide says a cream targets one spot, a roll-on does the same with clean hands, and a pump measures the amount you use. The base changes how the product feels on skin, so read the ingredient list. The FDA says it is still working to learn how much CBD is absorbed from skin cream.
How much CBD is good for chronic pain, and is 10 mg a day too much?
No amount is established as the right one for chronic pain in this research. The studies used very different amounts, and the route changes the picture: 250 mg per 3 fl. oz on the skin in the 2020 neuropathy trial, 50 mg by mouth daily in the fibromyalgia trial, and 5 mg per kilogram of body weight a day by mouth in the 2025 liver trial. Those are descriptions of what each study tested, not amounts to take.
On 10 mg, the research gives no direct answer. The liver trial’s dose was set by body weight, so it can’t be converted into 10 mg. Check the milligram count on your label, and have a pharmacist compare it with any medicines you take.
How does 10 mg of CBD make you feel?
The FDA lists the effects it has seen with CBD: changes in alertness, most commonly sleepiness, though insomnia can also occur; stomach effects such as diarrhea and decreased appetite; and changes in mood, most commonly irritability and agitation. The FDA also says there are many unanswered questions about the science, safety and quality of CBD products.
The closest human picture of how CBD feels comes from a sleep study, not a pain study. In a two-week pilot of primary insomnia (2025 insomnia pilot trial), 15 people took 150 mg of CBD sublingually before bed and 15 took placebo. Those on CBD reported greater calmness and clear-headedness, and were more likely to report dry mouth. Daytime cognitive performance was unaffected. The authors said larger controlled trials are needed.
What type of CBD is best for chronic pain?
The research doesn’t name a best type. The 2024 chemotherapy trial tested an isolate cream, and the 2020 neuropathy trial’s abstract describes a CBD oil without naming its spectrum. Nothing But Canna’s label guide describes the spectrums this way: full spectrum keeps the plant’s other cannabinoids, including a legal trace of THC; broad spectrum removes the THC; isolate is CBD only. Check the spectrum on the label and the THC line on the lab report. For how full-spectrum products carry THC, see full spectrum cbd gummies for pain.
Is CBD hard on the liver or kidneys?
The FDA says CBD can cause liver injury, and that harm can happen before you become aware of it. The clearest number comes from a 2025 trial in JAMA Intern Med (2025 liver trial abstract). It enrolled 201 healthy adults who took CBD twice a day by mouth for 28 days, at 5 mg per kilogram daily, or placebo. Eight participants (5.6%) on CBD had ALT or AST liver enzyme levels more than three times the upper limit of normal, against zero on placebo. Seven participants met withdrawal criteria for potential drug-induced liver injury. The authors wrote that their findings “underscore the need for further investigation on the long-term effects of CBD use.”
That trial used oral CBD, not a cream, so its liver result describes swallowed CBD. The NCCIH says some side effects, including abnormal liver-function tests and drug interactions, appear to be due to CBD itself rather than contaminants in CBD products. It adds that these effects were observed in some of the people who took part in studies of Epidiolex, the prescription CBD drug, before it was approved.
What should you not mix CBD with?
The FDA says CBD can affect how other drugs you are taking work. This guide has no list of specific drugs to avoid, so the practical step is to show your medicine list and the product label to a pharmacist before you add CBD.
Before you order
- Find the total CBD milligrams per container on the label, and the container size.
- Read the spectrum and the THC line on the lab report, and check that the report matches the lot you’ll receive.
- Confirm who makes and sells the product, and read the return terms before you pay.
- Note that FDA has not approved a CBD cream for pain, whatever the label says.
- Show your medicine list to a pharmacist.
By HealthDataConsortium.org Research Team
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.

